Evaluation of short-course durvalumab combined with dose-dense EC in the neoadjuvant setting for locally advanced luminal B/HER2(-) or triple-negative breast cancer.
Saved in:
| Title: | Evaluation of short-course durvalumab combined with dose-dense EC in the neoadjuvant setting for locally advanced luminal B/HER2(-) or triple-negative breast cancer. |
|---|---|
| Authors: | Devaux A; Oncology Unit of Grand Hopital de Charleroi, Rue du Campus des Viviers 1, Gilly, 6060, Charleroi, Belgium.; Laboratory of Translational Oncology, Institut de Pathologie et Génétique / Grand Hopital de Charleroi, Gosselies, Belgium., Beniuga G; Institut de Pathologie et Génétique, Gosselies, Belgium., Delrée P; Institut de Pathologie et Génétique, Gosselies, Belgium., Quaghebeur C; Oncology Unit of CHU UCL Namur, Sainte-Elisabeth Site, Namur, Belgium., Henry S; Oncology Unit of CHU UCL Namur, Sainte-Elisabeth Site, Namur, Belgium., Van Bockstal M; Department of Anatomopathology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Galant C; Department of Anatomopathology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Lefevre S; Oncology Unit of Grand Hopital de Charleroi, Rue du Campus des Viviers 1, Gilly, 6060, Charleroi, Belgium., Korman D; Oncology Unit of Grand Hopital de Charleroi, Rue du Campus des Viviers 1, Gilly, 6060, Charleroi, Belgium., Verschaeve V; Oncology Unit of Grand Hopital de Charleroi, Rue du Campus des Viviers 1, Gilly, 6060, Charleroi, Belgium., Lonchay C; Oncology Unit of Grand Hopital de Charleroi, Rue du Campus des Viviers 1, Gilly, 6060, Charleroi, Belgium., D'Hondt L; Oncology Unit of CHU UCL Namur, Godinne Site, Yvoir, Belgium., Berlière M; Gynecology Unit of Cliniques Universitaires Saint-Luc, Brussels, Belgium., van Marcke C; Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, and Pole of Medical Imaging, Radiotherapy and Oncology (MIRO), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Delmarcelle S; Pharmacology Unit of Grand Hopital de Charleroi, Charleroi, Belgium., Mine JM; Gynecology Unit of Grand Hopital de Charleroi, Charleroi, Belgium., Müller G; Institut de Pathologie et Génétique, Gosselies, Belgium., Myant N; Institut de Pathologie et Génétique, Gosselies, Belgium., Bar I; Laboratory of Translational Oncology, Institut de Pathologie et Génétique / Grand Hopital de Charleroi, Gosselies, Belgium., Haussy S; Laboratory of Translational Oncology, Institut de Pathologie et Génétique / Grand Hopital de Charleroi, Gosselies, Belgium., Merhi A; Institut de Pathologie et Génétique, Gosselies, Belgium., Petrone D; Laboratory of Translational Oncology, Institut de Pathologie et Génétique / Grand Hopital de Charleroi, Gosselies, Belgium., Coulie PG; Laboratory of GECE, de Duve Institute, UCLouvain, Brussels, Belgium., Canon JL; Oncology Unit of Grand Hopital de Charleroi, Rue du Campus des Viviers 1, Gilly, 6060, Charleroi, Belgium., Duhoux FP; Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, and Pole of Medical Imaging, Radiotherapy and Oncology (MIRO), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium., Carrasco J; Oncology Unit of Grand Hopital de Charleroi, Rue du Campus des Viviers 1, Gilly, 6060, Charleroi, Belgium. javier.carrasco@ghdc.be.; Laboratory of Translational Oncology, Institut de Pathologie et Génétique / Grand Hopital de Charleroi, Gosselies, Belgium. javier.carrasco@ghdc.be. |
| Source: | Breast cancer research : BCR [Breast Cancer Res] 2025 Nov 28; Vol. 27 (1), pp. 212. Date of Electronic Publication: 2025 Nov 28. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II |
| Journal Info: | Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
